Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

2.

Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.

Umanah TA, Ncayiyana JR, Nyasulu PS.

Trans R Soc Trop Med Hyg. 2015 May;109(5):340-8. doi: 10.1093/trstmh/trv025. Epub 2015 Mar 18. Review.

PMID:
25787727
3.

Treatment of multidrug-resistant tuberculosis in Thailand.

Maranetra KN.

Chemotherapy. 1996;42 Suppl 3:10-5; discussion 30-3. Review.

PMID:
8980862
4.

Fluoroquinolones for the treatment of tuberculosis in children.

Thee S, Garcia-Prats AJ, Donald PR, Hesseling AC, Schaaf HS.

Tuberculosis (Edinb). 2015 May;95(3):229-45. doi: 10.1016/j.tube.2015.02.037. Epub 2015 Feb 14. Review.

PMID:
25797610
5.

The changing face of tuberculosis.

Huebner RE, Castro KG.

Annu Rev Med. 1995;46:47-55. Review.

PMID:
7598480
6.

Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities.

McAnaw SE, Hesseling AC, Seddon JA, Dooley KE, Garcia-Prats AJ, Kim S, Jenkins HE, Schaaf HS, Sterling TR, Horsburgh CR.

Int J Infect Dis. 2017 Mar;56:194-199. doi: 10.1016/j.ijid.2016.11.423. Epub 2016 Dec 9. Review.

7.

Tuberculosis pharmacotherapy: strategies to optimize patient care.

Mitnick CD, McGee B, Peloquin CA.

Expert Opin Pharmacother. 2009 Feb;10(3):381-401. doi: 10.1517/14656560802694564 . Review.

8.

Infection caused by Mycobacterium tuberculosis.

Peloquin CA, Berning SE.

Ann Pharmacother. 1994 Jan;28(1):72-84. Review.

PMID:
8123968
9.

Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.

Ghimire S, Van't Boveneind-Vrubleuskaya N, Akkerman OW, de Lange WC, van Soolingen D, Kosterink JG, van der Werf TS, Wilffert B, Touw DJ, Alffenaar JW.

J Antimicrob Chemother. 2016 Oct;71(10):2691-703. doi: 10.1093/jac/dkw164. Epub 2016 May 26. Review.

PMID:
27231277
10.

Treatment of pulmonary tuberculosis.

Nunn A, Phillips PP, Abubakar I.

Curr Opin Pulm Med. 2013 May;19(3):273-9. doi: 10.1097/MCP.0b013e32835f27f8. Review.

PMID:
23528955
11.

Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.

Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R.

AIDS. 2012 Nov 13;26(17):2121-33. doi: 10.1097/QAD.0b013e3283565dd1. Review.

12.

Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.

Arentz M, Pavlinac P, Kimerling ME, Horne DJ, Falzon D, Sch√ľnemann HJ, Royce S, Dheda K, Walson JL; ART study group.

PLoS One. 2012;7(11):e47370. doi: 10.1371/journal.pone.0047370. Epub 2012 Nov 5. Review.

13.

Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials.

Moodley R, Godec TR; STREAM Trial Team.

Eur Respir Rev. 2016 Mar;25(139):29-35. doi: 10.1183/16000617.0080-2015. Review.

14.

Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.

Laurence YV, Griffiths UK, Vassall A.

Pharmacoeconomics. 2015 Sep;33(9):939-55. doi: 10.1007/s40273-015-0279-6. Review.

15.

Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis.

Gopalan N, Chandrasekaran P, Swaminathan S, Tripathy S.

AIDS Res Ther. 2016 Sep 26;13:34. eCollection 2016. Review.

16.

The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains.

McBryde ES, Meehan MT, Doan TN, Ragonnet R, Marais BJ, Guernier V, Trauer JM.

Int J Infect Dis. 2017 Mar;56:14-20. doi: 10.1016/j.ijid.2017.01.031. Epub 2017 Feb 2. Review.

17.

Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis.

Wu S, Zhang Y, Sun F, Chen M, Zhou L, Wang N, Zhan S.

Am J Ther. 2016 Mar-Apr;23(2):e521-30. doi: 10.1097/01.mjt.0000433951.09030.5a. Review.

PMID:
24284652
18.

Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.

Thomas BE, Shanmugam P, Malaisamy M, Ovung S, Suresh C, Subbaraman R, Adinarayanan S, Nagarajan K.

PLoS One. 2016 Jan 25;11(1):e0147397. doi: 10.1371/journal.pone.0147397. eCollection 2016. Review.

19.

Treatment Options for HIV-Associated Tuberculosis.

Onyebujoh PC, Ribeiro I, Whalen CC.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S35-45. Review.

20.

Tuberculosis in patients infected with the human immunodeficiency virus.

Gerard M.

Monaldi Arch Chest Dis. 1998 Dec;53(6):688-92. Review. No abstract available.

PMID:
10063346

Supplemental Content

Support Center